HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice

Hepatocellular carcinoma (HCC) is one of the most common and deadly tumors worldwide. Management of HCC depends on reliable biomarkers for screening, diagnosis, and monitoring of the disease, as well as predicting response towards therapy and safety. To date, imaging has been the established standar...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Sophie Schlosser, Deniz Tümen, Barbara Volz, Katja Neumeyer, Niklas Egler, Claudia Kunst, Hauke Christian Tews, Stephan Schmid, Arne Kandulski, Martina Müller, Karsten Gülow
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2022-11-01
Serie:	Frontiers in Oncology
Soggetti:	hepatocellular carcinoma biomarker personalized medicine alpha-fetoprotein liquid biopsy circulating tumor cells
Accesso online:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1016952/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!